Hospital price transparency: A primer.

Area of Science:

• Health economics
• Healthcare policy
• Health informatics

Background:

• US healthcare spending is projected to reach nearly $6 trillion by 2027.
• Hospital Price Transparency (HPT) regulations were implemented in January 2021.
• Inconsistent compliance and data standardization challenges hinder the effectiveness of current HPT rules.

Purpose of the Study:

• To review the economic implications of Hospital Price Transparency (HPT).
• To delineate federal requirements for HPT.
• To explore how HPT can potentially reduce US healthcare spending, particularly drug costs.

Main Methods:

• Review of economic implications of HPT.
• Analysis of federal HPT requirements.
• Assessment of HPT's potential impact on healthcare spending and drug costs.

Main Results:

• Transparent pricing can reduce cost variation in simpler markets, but its impact in complex healthcare settings is less predictable.
• Hospitals are required to publish machine-readable charge data and prices for at least 300 shoppable services.
• Compliance with HPT rules has been inconsistent, and varied data formats impede data utilization.

Conclusions:

• Visible prices can empower patient choices, enhance payer negotiations, and promote market competition.
• Low compliance limits regulatory bodies' ability to assess market impacts.
• HPT is foundational for value-based purchasing, competitive pricing, and future payment reforms, though it doesn't address all cost drivers.